MedPath

Ramipril

These highlights do not include all the information needed to use Ramipril Capsules safely and effectively. See full prescribing information for Ramipril Capsules. RAMIPRIL capsules, for oral useInitial U.S. Approval: 1991

Approved
Approval ID

d13045d0-80fb-447a-aee0-3c260b26895b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 6, 2017

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ramipril

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-0681
Application NumberANDA077900
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ramipril
Product Specifications
Route of AdministrationORAL
Effective DateJune 6, 2016
FDA Product Classification

INGREDIENTS (6)

FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
RAMIPRILActive
Quantity: 1.25 mg in 1 1
Code: L35JN3I7SJ
Classification: ACTIB
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ramipril - FDA Drug Approval Details